EDGAR Filing Documents for 0001683168-22-007290

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:

SEC Accession No. 0001683168-22-007290

Filing Date

2022-11-07

Accepted

2022-11-07 07:30:25

Documents

Period of Report

2022-09-30

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 10-Q	sunshine_i10q-093022.htm iXBRL	10-Q	509637
2	CERTIFICATION	sunshine_ex3101.htm	EX-31.1	10264
3	CERTIFICATION	sunshine_ex3102.htm	EX-31.2	10249
4	CERTIFICATION	sunshine_ex3201.htm	EX-32.1	4274
5	GRAPHIC	s1.jpg	GRAPHIC	21121
6	GRAPHIC	s2.jpg	GRAPHIC	27197
7	GRAPHIC	s3.jpg	GRAPHIC	27637
	Complete submission text file	0001683168-22-007290.txt		2687244

Data Files

Seq	Description	Document	Type	Size
8	XBRL SCHEMA FILE	sbfm-20220930.xsd	EX-101.SCH	22191
9	XBRL CALCULATION FILE	sbfm-20220930_cal.xml	EX-101.CAL	36355
10	XBRL DEFINITION FILE	sbfm-20220930_def.xml	EX-101.DEF	108304
11	XBRL LABEL FILE	sbfm-20220930_lab.xml	EX-101.LAB	171066
12	XBRL PRESENTATION FILE	sbfm-20220930_pre.xml	EX-101.PRE	151896
39	EXTRACTED XBRL INSTANCE DOCUMENT	sunshine_i10q-093022_htm.xml	XML	220094

Mailing Address 6500 TRANS-CANADA HIGHWAY 4TH FLOOR POINTE-CLAIRE A8 H9R 0A5

Business Address 6500 TRANS-CANADA HIGHWAY 4TH FLOOR POINTE-CLAIRE A8 H9R 0A5 514-426-6161

Sunshine Biopharma, Inc (Filer) CIK: 0001402328 (see all company filings)